Results for tag: "Olprinone"

Olprinone is a cardiovascular drug used to treat congestive heart failure and other cardiac conditions. It is a phosphodiesterase inhibitor that works by blocking the breakdown of cyclic adenosine monophosphate (cAMP), a molecule that helps regulate the heart's contractions. Olprinone is typically administered intravenously and is used to improve cardiac output and reduce symptoms of heart failure. It is also used to reduce the risk of death in patients with severe heart failure. Olprinone is a relatively new drug, having been approved by the US Food and Drug Administration in 2019. It is currently available in the United States, Europe, and other countries. The Olprinone market is growing rapidly, as it is increasingly being used to treat a variety of cardiac conditions. It is expected to continue to grow in the coming years, as more patients are prescribed the drug and as new uses are discovered. Some companies in the Olprinone market include Merck, Pfizer, and Novartis. Show Less Read more